THE PROBLEM OF NEUTRALIZING ANTIBODIES IN MANAGEMENT OF MULTIPLE SCLEROSIS
It is known that the interferon beta therapy is more effective for multiple sclerosis. The literature review focuses on the problem of neutralizing antibodies (NAbs) in interferon beta therapy of multiple sclerosis for children and adolescents. The authors provide domestic and foreign data concernin...
Main Authors: | B.I. Bursagova, L.A. Pak, V.M. Studenikin, L.M. Kuzenkova |
---|---|
Format: | Article |
Language: | English |
Published: |
Paediatrician Publishers, LLC
2011-10-01
|
Series: | Pediatričeskaâ Farmakologiâ |
Online Access: | https://pf.spr-journal.ru/jour/article/view/1330 |
Similar Items
-
THE PROBLEM OF NEUTRALIZING ANTIBODIES IN MANAGEMENT OF MULTIPLE SCLEROSIS
by: B.I. Bursagova, et al.
Published: (2011-10-01) -
EХPERIENCE IN INTERFERON β-1A USE FOR TREATMENT OF MULTIPLE SCLEROSIS IN CHILDREN
by: L. M. Kuzenkova, et al.
Published: (2013-09-01) -
Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis
by: Paul I. Creeke, et al.
Published: (2013-01-01) -
NEUROPEDIATRIC ASPECTS OF SEDATIVE MEDICINES USING IN THE TREATMENT OF CHILDREN AND ADOLESCENTS
by: V.M. Studenikin, et al.
Published: (2011-01-01) -
NEUROPEDIATRIC ASPECTS OF SEDATIVE MEDICINES USING IN THE TREATMENT OF CHILDREN AND ADOLESCENTS
by: V.M. Studenikin, et al.
Published: (2011-01-01)